Targeted therapy of hormone receptor-positive breast cancer harboring PIK3CA and AKT1 genetic aberrations

被引：0
|
作者：
Shariati, Maryam
Evans, Kurt W.
Scott, Stephen M.
Chen, Huiqin
Meric-Bernstam, Funda
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
135
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Activating PIK3CA and AKT mutations in triple-receptor-negative breast cancer
    Gonzalez-Angulo, Ana M.
    Hennessy, Bryan T.
    Stemke-Hale, Katherine
    Broglio, Kristine
    Carey, Mark
    Davies, Michael
    Meric-Bernstam, Funda
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3540S - 3540S
  • [22] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    中华医学杂志英文版, 2020, 133 (19) : 2338 - 2345
  • [23] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [24] Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
    Herberts, Cameron
    Murtha, Andrew J.
    Fu, Simon
    Wang, Gang
    Schonlau, Elena
    Xue, Hui
    Lin, Dong
    Gleave, Anna
    Yip, Steven
    Angeles, Arkhjamil
    Hotte, Sebastien
    Tran, Ben
    North, Scott
    Taavitsainen, Sinja
    Beja, Kevin
    Vandekerkhove, Gillian
    Ritch, Elie
    Warner, Evan
    Saad, Fred
    Iqbal, Nayyer
    Nykter, Matti
    Gleave, Martin E.
    Wang, Yuzhuo
    Annala, Matti
    Chi, Kim N.
    Wyatt, Alexander W.
    EUROPEAN UROLOGY, 2020, 78 (06) : 834 - 844
  • [25] Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
    Tian, Wen
    Huang, Yingzhao
    Sun, Liying
    Guo, Yang
    Zhao, Sen
    Lin, Mao
    Dong, Xiying
    Zhong, Wenyao
    Yin, Yuehan
    Chen, Zefu
    Zhang, Nan
    Zhang, Yuanqiang
    Wang, Lianlei
    Lin, Jiachen
    Yan, Zihui
    Yang, Xinzhuang
    Zhao, Junhui
    Qiu, Guixing
    Zhang, Jianguo
    Wu, Zhihong
    Wu, Nan
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [26] Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer
    Arnedos, M.
    Scott, V.
    Job, B.
    De La Cruz, J.
    Commo, F.
    Mathieu, M. C.
    Wolp-Diniz, R.
    Richon, C.
    Campone, M.
    Bachelot, T.
    Dalenc, F.
    Dessen, P.
    Lacroix, L.
    Lazar, V.
    Soria, J. C.
    Delaloge, S.
    Andre, F.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) : 2293 - 2299
  • [27] Concordance of PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: A systematic literature review
    Aguilar, Alejandra
    Dean, Joni
    Anderson, Elizabeth
    Mollon, Lea
    Davis, Lisa
    Warholak, Terri
    Aizer, Ayal
    Platt, Emma
    Bardiya, Aditya
    Tang, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Hotspot mutations of PIK3CA and AKT1 genes are absent in multiple myeloma
    Ismail, Said I.
    Mahmoud, Ismail S.
    Msallam, Mohammed M.
    Sughayer, Maher A.
    LEUKEMIA RESEARCH, 2010, 34 (06) : 824 - 826
  • [29] Identification of PIK3CA aberrations associated with telomere length in breast cancer
    Dirican, Ebubekir
    Velidedeoglu, Mehmet
    Ilvan, Sennur
    Ozturk, Tulin
    Altintas, Tansu
    Ayni, Emine Bilge
    Ilvan, Ahmet
    GENE REPORTS, 2020, 19
  • [30] PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer
    Marino, Elena
    Mauro, Cristian
    Belloni, Elena
    Picozzi, Marco
    Favalli, Valentina
    Cassatella, Maria Cristina
    Zorzino, Laura
    Giaco, Luciano
    Pelicci, Pier Giuseppe
    Barberis, Massimo
    Sandri, Maria Teresa
    Bernard, Loris
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
12345